Antibiofilm activity and post antifungal effect of lemongrass oil on clinical Candida dubliniensis isolate

South African Journal of Botany

Volumn 78, Issue , 2012, Pages 37-43

  Taweechaisupapong, S ^a   Ngaonee, P ^a   Patsuk, P ^a   Pitiphat, W ^a   Khunkitti, W ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Antifungal activity; Biofilm; Broth microdilution; Candida dubliniensis; Essential oils; Post antifungal effect

Indexed keywords

ANTIMICROBIAL ACTIVITY; BIOFILM; COLONIZATION; CONCENTRATION (COMPOSITION); DEVELOPMENTAL BIOLOGY; ESSENTIAL OIL; FUNGAL DISEASE; FUNGICIDE; GRASS; GROWTH RESPONSE; INHIBITOR; PLANKTON; SALT; VEGETABLE OIL; YEAST;

CANDIDA DUBLINIENSIS; CYMBOPOGON CITRATUS;

EID: 84855968743     PISSN: 02546299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sajb.2011.04.003     Document Type: Article

References (43)

1. Abe S., Sato Y., Inoue S., Ishibashi H., Maruyama N., Takizawa T., Oshima H., Yamaguchi H. Anti-Candida albicans activity of essential oils including Lemongrass (Cymbopogon citratus) oil and its component, citral. Japanese Journal of Medical Mycology 2003, 44:285-291.
2. Bachmann S.P., VandeWalle K., Ramage G., Patterson T.F., Wickes B.L., Graybill J.R., Lopez-Ribot J.L. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrobial Agents and Chemotherapy 2002, 46:3591-3596.
3. Bard M., Albrecht M.R., Gupta N., Guynn C.J., Stillwell W. Geraniol interferes with membrane functions in strains of Candida and Saccharomyces. Lipids 1988, 23:534-538.
4. Braga P.C., Dal Sasso M. Morphostructural alterations of Candida albicans induced by thymol. A scanning electron microscopy study. Journal of Chemotherapy 2005, 17(supplement 3):109.
5. Cannon R.D., Chaffin W.L. Oral colonization by Candida albicans. Critical Reviews in Oral Biology and Medicine 1999, 10:359-383.
6. Cassella S., Cassella J.P. The essential oil of lemon grass (Cymbopogon citratus) demonstrates a superior antifungal activity compared with tea tree (Melalueca alternifolia) or lavender (Lavandula angustifolia). Focus on Alternative and Complementary Therapies 2002, 7:88.
7. Chandra J., Mukherjee P.K., Leidich S.D., Faddoul F.F., Hoyer L.L., Douglas L.J., Ghannoum M.A. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. Journal of Dental Research 2001, 80:903-908.
8. Craig W.A., Gudmundsson S. The postantibiotic effect. Antibiotics in Laboratory Medicine 1996, 296-329. Williams & Wilkins, Baltimore, MD. 4th ed. V. Lorian (Ed.).
9. Crump J.A., Collignon P.J. Intravascular catheter-associated infections. European Journal of Clinical Microbiology & Infectious Diseases 2000, 19:1-8.
10. Dalleau S., Cateau E., Berges T., Berjeaud J.M., Imbert C. In vitro activity of terpenes against Candida biofilms. International Journal of Antimicrobial Agents 2008, 31:572-576.
11. Douglas L.J. Candida biofilms and their role in infection. Trends in Microbiology 2003, 11:30-36.
12. Eggimann P., Garbino J., Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. The Lancet Infectious Diseases 2003, 3:685-702.
13. Ell S.R. Candida 'the cancer of silastic'. The Journal of Laryngology and Otology 1996, 110:240-242.
14. Ellepola A.N., Samaranayake L.P. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. Oral Diseases 1998, 4:260-267.
15. Gilfillan G.D., Sullivan D.J., Haynes K., Parkinson T., Coleman D.C., Gow N.A. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 1998, 144:829-838.
16. Hammer K.A., Carson C.F., Riley T.V. Antimicrobial activity of essential oils and other plant extracts. Journal of Applied Microbiology 1999, 86:985-990.
17. Hawser S. Adhesion of different Candida spp. to plastic: XTT formazan determinations. Journal of Medical and Veterinary Mycology 1996, 34:407-410.
18. Hawser S.P., Douglas L.J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infection and Immunity 1994, 62:915-921.
19. Helal G.A., Sarhan M.M., Abu Shahla A.N., Abou El-Khair E.K. Effect of Cymbopogon citratus L. essential oil on growth and morphogenesis of Saccharomyces cerevisiae ML2-strain. Journal of Basic Microbiology 2006, 46:375-386.
20. Kalemba D., Kunicka A. Antibacterial and antifungal properties of essential oils. Current Medicinal Chemistry 2003, 10:813-829.
21. Kojic E.M., Darouiche R.O. Candida infections of medical devices. Clinical Microbiology Reviews 2004, 17:255-267.
22. Kuhn D.M., Chandra J., Mukherjee P.K., Ghannoum M.A. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infection and Immunity 2002, 70:878-888.
23. Lowdin E., Odenholt-Tornqvist I., Bengtsson S., Cars O. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations. Antimicrobial Agents and Chemotherapy 1993, 37:2200-2205.
24. MacKenzie F.M., Gould I.M. The post-antibiotic effect. The Journal of Antimicrobial Chemotherapy 1993, 32:519-537.
25. Martinez M., Lopez-Ribot J.L., Kirkpatrick W.R., Coco B.J., Bachmann S.P., Patterson T.F. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. Journal of Clinical Microbiology 2002, 40:3135-3139.
26. Moran G.P., Sanglard D., Donnelly S.M., Shanley D.B., Sullivan D.J., Coleman D.C. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrobial Agents and Chemotherapy 1998, 42:1819-1830.
27. National Committee for Clinical Laboratory Standards Reference method for broth dilution susceptibility testing of yeasts. Approved Standard. Document M27-A2 2002, NCCLS, Wayne, Pa. 2nd ed.
28. Paranagama P.A., Abeysekera K.H., Abeywickrama K., Nugaliyadde L. Fungicidal and anti-aflatoxigenic effects of the essential oil of Cymbopogon citratus (DC.) Stapf. (lemongrass) against Aspergillus flavus Link. isolated from stored rice. Letters in Applied Microbiology 2003, 37:86-90.
29. Presterl E., Daxbock F., Graninger W., Willinger B. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clinical Microbiology and Infection 2007, 13:1072-1076.
30. Ramage G., Vande Walle K., Wickes B.L., Lopez-Ribot J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrobial Agents and Chemotherapy 2001, 45:2475-2479.
31. Ramage G., Martinez J.P., Lopez-Ribot J.L. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Research 2006, 6:979-986.
32. Ramirez-Amador V., Esquivel-Pedraza L., Sierra-Madero J., Anaya-Saavedra G., Gonzalez-Ramirez I., Ponce-de-Leon S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients-a 12-year study in a referral center in Mexico. Medicine 2003, 82:39-50.
33. Rauber Cda S., Guterres S.S., Schapoval E.E. LC determination of citral in Cymbopogon citratus volatile oil. Journal of Pharmaceutical and Biomedical Analysis 2005, 37:597-601.
34. Scalarone G.M., Mikami Y., Kurita N., Ichihara Y., Yazawa K., Miyaji M. Turbidometric characterization of the postantifungal effect: comparative studies with amphotericin B, 5-fluorocytosine and miconazole on Candida albicans. Mycoses 1991, 34:297-302.
35. Schaneberg B.T., Khan I.A. Comparison of extraction methods for marker compounds in the essential oil of lemon grass by GC. Journal of Agricultural and Food Chemistry 2002, 50:1345-1349.
36. Shuford J.A., Piper K.E., Steckelberg J.M., Patel R. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagnostic Microbiology and Infectious Disease 2007, 57:277-281.
37. Singh N., Wagener M.M., Marino I.R., Gayowski T. Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation 2002, 73:63-67.
38. Sullivan D.J., Westerneng T.J., Haynes K.A., Bennett D.E., Coleman D.C. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995, 141:1507-1521.
39. Taweechaisupapong S., Klanrit P., Singhara S., Pitiphat W., Wongkham S. Inhibitory effect of Streblus asper leaf-extract on adhesion of Candida albicans to denture acrylic. Journal of Ethnopharmacology 2006, 106:414-417.
40. Taweechaisupapong S., Singhara S., Lertsatitthanakorn P., Khunkitti W. Antimicrobial effects of Boesenbergia pandurata and Piper sarmentosum leaf extracts on planktonic cells and biofilm of oral pathogens. Pakistan Journal of Pharmaceutical Sciences 2010, 23:224-231.
41. Tognolini M., Barocelli E., Ballabeni V., Bruni R., Bianchi A., Chiavarini M., Impicciatore M. Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity. Life Sciences 2006, 78:1419-1432.
42. Turnidge J.D., Gudmundsson S., Vogelman B., Craig W.A. The postantibiotic effect of antifungal agents against common pathogenic yeasts. The Journal of Antimicrobial Chemotherapy 1994, 34:83-92.
43. Wannissorn B., Jarikasem S., Soontorntanasart T. Antifungal activity of lemon grass oil and lemongrass oil cream. Phytotherapy Research 1996, 10:551-554.